Russell Investments Group Ltd. increased its holdings in SeaSpine Holdings Corporation (NASDAQ:SPNE) by 14.2% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 278,884 shares of the medical equipment provider’s stock after purchasing an additional 34,637 shares during the period. Russell Investments Group Ltd. owned 2.08% of SeaSpine worth $3,130,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Dimensional Fund Advisors LP lifted its holdings in SeaSpine by 22.9% in the 2nd quarter. Dimensional Fund Advisors LP now owns 368,631 shares of the medical equipment provider’s stock worth $4,247,000 after purchasing an additional 68,737 shares in the last quarter. Gilder Gagnon Howe & Co. LLC bought a new stake in SeaSpine in the 3rd quarter worth approximately $4,024,000. Vanguard Group Inc. increased its stake in SeaSpine by 10.6% in the 2nd quarter. Vanguard Group Inc. now owns 334,832 shares of the medical equipment provider’s stock worth $3,857,000 after acquiring an additional 32,191 shares during the last quarter. The Manufacturers Life Insurance Company increased its stake in SeaSpine by 2.3% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 249,499 shares of the medical equipment provider’s stock worth $2,874,000 after acquiring an additional 5,655 shares during the last quarter. Finally, Hodges Capital Management Inc. increased its stake in SeaSpine by 50.0% in the 3rd quarter. Hodges Capital Management Inc. now owns 180,000 shares of the medical equipment provider’s stock worth $2,020,000 after acquiring an additional 60,000 shares during the last quarter. 43.43% of the stock is currently owned by institutional investors.

A number of analysts have issued reports on the company. Piper Jaffray Companies reaffirmed a “buy” rating and issued a $22.00 price objective on shares of SeaSpine in a research note on Sunday, August 20th. Zacks Investment Research downgraded SeaSpine from a “buy” rating to a “hold” rating in a research note on Wednesday, September 13th. BTIG Research reaffirmed a “buy” rating on shares of SeaSpine in a research note on Monday, November 6th. Ladenburg Thalmann Financial Services assumed coverage on SeaSpine in a research note on Thursday. They issued a “buy” rating and a $20.00 price objective on the stock. Finally, HC Wainwright reaffirmed a “buy” rating and issued a $15.00 price objective on shares of SeaSpine in a research note on Friday, November 3rd. One investment analyst has rated the stock with a sell rating and five have issued a buy rating to the stock. The company has a consensus rating of “Buy” and an average target price of $17.25.

Shares of SeaSpine Holdings Corporation (NASDAQ SPNE) opened at $10.05 on Monday. SeaSpine Holdings Corporation has a 12 month low of $6.31 and a 12 month high of $13.46.

COPYRIGHT VIOLATION NOTICE: This article was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this article on another publication, it was illegally stolen and republished in violation of United States & international copyright and trademark law. The correct version of this article can be read at https://www.thecerbatgem.com/2017/12/18/seaspine-holdings-corporation-spne-shares-bought-by-russell-investments-group-ltd.html.

About SeaSpine

SeaSpine Holdings Corporation is a medical technology company. The Company is focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. The Company operates through the development, manufacture and marketing of orthobiologics and spinal fusion hardware segment.

Want to see what other hedge funds are holding SPNE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SeaSpine Holdings Corporation (NASDAQ:SPNE).

Institutional Ownership by Quarter for SeaSpine (NASDAQ:SPNE)

Receive News & Stock Ratings for SeaSpine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SeaSpine and related stocks with our FREE daily email newsletter.